Citius Pharmaceuticals, Inc. Professional Fees
Citius Pharmaceuticals, Inc. (CTXR) reported Professional Fees of $84.73 thousand for the 12-month period ending 2024-09-30, per its 10-K filed 2024-12-27.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ProfessionalFees · last filed 2024-12-27
- Citius Pharmaceuticals, Inc. professional fees for the quarter ending 2014-06-30 was $3.36K, a 5.00% increase year-over-year.
- Citius Pharmaceuticals, Inc. professional fees for the quarter ending 2014-03-31 was $9.40K, a 8.62% increase year-over-year.
- Citius Pharmaceuticals, Inc. professional fees for the quarter ending 2013-12-31 was $0.00.
- Citius Pharmaceuticals, Inc. professional fees for the quarter ending 2013-09-30 was $13.38K, a 242.42% increase year-over-year.
- Citius Pharmaceuticals, Inc. professional fees for fiscal 2024 was $84.73K.
- Citius Pharmaceuticals, Inc. professional fees for fiscal 2013 was $25.23K, a 62.12% increase from fiscal 2012.
- Citius Pharmaceuticals, Inc. professional fees for fiscal 2012 was $15.56K, a 15.68% increase from fiscal 2011.
- Citius Pharmaceuticals, Inc. professional fees for fiscal 2011 was $13.45K.
| Period end | Professional Fees 1 month | Professional Fees 3 month | Professional Fees 6 month | Professional Fees 9 month | Professional Fees 10 month | Professional Fees 12 month | Professional Fees 13 month | Professional Fees 16 month | Professional Fees 19 month | Professional Fees 22 month | Professional Fees 25 month | Professional Fees 28 month | Professional Fees 31 month | Professional Fees 34 month | Professional Fees 37 month | Professional Fees 40 month | Professional Fees 43 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | $84.73K 10-K · filed 2024-12-27 | ||||||||||||||||
| 2014-06-30 | $3.36K 10-Q · filed 2014-08-14 | $12.76K derived: sum of 2 quarters · filed 2014-08-14 | $12.76K 10-Q · filed 2014-08-14 | $26.13K derived: sum of 4 quarters · filed 2014-08-14 | |||||||||||||
| 2014-03-31 | $9.40K 10-Q · filed 2014-05-15 | $9.40K 10-Q · filed 2014-05-15 | $22.77K derived: sum of 3 quarters · filed 2014-05-15 | $25.97K derived: sum of 4 quarters · filed 2014-08-14 | $79.13K 10-Q · filed 2014-05-15 | ||||||||||||
| 2013-12-31 | $0.00 10-Q · filed 2014-02-19 | $13.38K derived: sum of 2 quarters · filed 2014-02-19 | $16.57K derived: sum of 3 quarters · filed 2014-08-14 | $25.23K derived: sum of 4 quarters · filed 2014-08-14 | $69.73K 10-Q · filed 2014-02-19 | ||||||||||||
| 2013-09-30 | $13.38K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-06 | $16.57K derived: sum of 2 quarters · filed 2014-08-14 | $25.23K derived: sum of 3 quarters · filed 2014-08-14 | $25.23K 10-K · filed 2014-02-06 | $69.73K 10-K · filed 2014-02-06 | ||||||||||||
| 2013-06-30 | $3.20K 10-Q · filed 2014-08-14 | $11.85K derived: sum of 2 quarters · filed 2014-08-14 | $11.85K 10-Q · filed 2014-08-14 | $15.76K derived: sum of 4 quarters · filed 2014-08-14 | $56.36K 10-Q · filed 2013-09-18 | ||||||||||||
| 2013-03-31 | $8.65K 10-Q · filed 2014-05-15 | $8.65K 10-Q · filed 2014-05-15 | $12.56K derived: sum of 3 quarters · filed 2014-05-15 | $15.51K derived: sum of 4 quarters · filed 2014-05-15 | $53.16K 10-Q · filed 2013-05-13 | ||||||||||||
| 2012-12-31 | $0.00 10-Q · filed 2014-02-19 | $3.91K derived: sum of 2 quarters · filed 2014-02-19 | $6.86K derived: sum of 3 quarters · filed 2014-02-19 | $13.43K derived: sum of 4 quarters · filed 2014-02-19 | $44.51K 10-Q · filed 2013-02-08 | ||||||||||||
| 2012-09-30 | $3.91K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-06 | $6.86K derived: sum of 2 quarters · filed 2014-02-06 | $13.43K derived: sum of 3 quarters · filed 2014-02-06 | $15.56K 10-K · filed 2014-02-06 | $44.51K 10-K · filed 2013-01-15 | ||||||||||||
| 2012-06-30 | $2.95K 10-Q · filed 2013-09-18 | $9.52K derived: sum of 2 quarters · filed 2013-09-18 | $11.65K 10-Q · filed 2013-09-18 | $12.90K derived: sum of 4 quarters · filed 2013-09-18 | $40.60K 10-Q · filed 2012-08-17 | ||||||||||||
| 2012-03-31 | $6.57K 10-Q · filed 2013-05-13 | $8.70K 10-Q · filed 2013-05-13 | $9.95K derived: sum of 3 quarters · filed 2013-05-13 | $12.55K derived: sum of 4 quarters · filed 2013-05-13 | $37.65K 10-Q · filed 2012-05-11 | ||||||||||||
| 2011-12-31 | $2.13K 10-Q · filed 2013-02-08 | $3.38K derived: sum of 2 quarters · filed 2013-02-08 | $5.98K derived: sum of 3 quarters · filed 2013-02-08 | $7.58K derived: sum of 4 quarters · filed 2013-02-08 | $31.08K 10-Q · filed 2012-02-14 | ||||||||||||
| 2011-09-30 | $1.25K derived: 10-K 12 month − 10-Q 9 month · filed 2013-01-15 | $3.85K derived: sum of 2 quarters · filed 2013-01-15 | $5.45K derived: sum of 3 quarters · filed 2013-01-15 | $13.45K 10-K · filed 2013-01-15 | $28.95K 10-K · filed 2012-01-13 | ||||||||||||
| 2011-06-30 | $2.60K 10-Q · filed 2012-08-17 | $4.20K derived: sum of 2 quarters · filed 2012-08-17 | $12.20K 10-Q · filed 2012-08-17 | $27.70K 10-Q · filed 2011-08-26 | |||||||||||||
| 2011-03-31 | $1.60K 10-Q · filed 2012-05-11 | $9.60K 10-Q · filed 2012-05-11 | |||||||||||||||
| 2010-12-31 | $8.00K 10-Q · filed 2012-02-14 | ||||||||||||||||
| 2010-09-30 | $15.50K 10-K · filed 2012-01-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |